Literature DB >> 15061721

Viral load in tissues during the early and chronic phase of non-pathogenic SIVagm infection.

A Gueye1, O M Diop, M J Y Ploquin, C Kornfeld, A Faye, M-C Cumont, B Hurtrel, F Barré-Sinoussi, M C Müller-Trutwin.   

Abstract

African green monkeys (AGMs) persistently infected with SIVagm do not develop AIDS, although their plasma viremia levels can reach those reported for pathogenic HIV-1 and SIVmac infections. In contrast, the viral burden in lymph nodes in SIVagm-infected AGMs is generally lower in comparison with HIV/SIVmac pathogenic infections, at least during the chronic phase of SIVagm infection. We searched for the primary targets of viral replication, which might account for the high viremias in SIVagm-infected AGMs. We evaluated for the first time during primary infection SIVagm dissemination in various lymphoid and non-lymphoid tissues. Sixteen distinct organs at a time point corresponding to maximal virus production were analyzed for viral RNA and DNA load. At days 8 and 9 p.i., viral RNA could be detected in a wide range of tissues, such as jejunum, spleen, mesenteric lymph nodes, thymus and lung. Quantification of viral DNA and RNA as well as of productively infected cells revealed that viral replication during this early phase takes place mainly in secondary lymphoid organs and in the gut (5 x 10(4)-5 x 10(8) RNA copies/10(6) cells). By 4 years p.i., RNA copy numbers were below detection level in thymus and lung. Secondary lymphoid organs displayed 6 x 10(2)-2 x 10(6) RNA copies/10(6) cells, while some tissue fragments of ileum and jejunum still showed high viral loads (up to 10(9) copies/10(6) cells). Altogether, these results indicate a rapid dissemination of SIVagm into lymphoid tissues, including the small intestine. The latter, despite showing marked regional variations, most likely contributes significantly to the high levels of viremia observed during SIVagm infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15061721     DOI: 10.1111/j.1600-0684.2004.00057.x

Source DB:  PubMed          Journal:  J Med Primatol        ISSN: 0047-2565            Impact factor:   0.667


  37 in total

1.  The well-tempered SIV infection: Pathogenesis of SIV infection in natural hosts in the wild, with emphasis on virus transmission and early events post-infection that may contribute to protection from disease progression.

Authors:  Kevin Raehtz; Ivona Pandrea; Cristian Apetrei
Journal:  Infect Genet Evol       Date:  2016-07-06       Impact factor: 3.342

2.  Plasmacytoid Dendritic Cell Infection and Sensing Capacity during Pathogenic and Nonpathogenic Simian Immunodeficiency Virus Infection.

Authors:  Simon P Jochems; Beatrice Jacquelin; Lise Chauveau; Nicolas Huot; Gaël Petitjean; Alice Lepelley; Anne-Sophie Liovat; Mickaël J Ploquin; Emily K Cartwright; Steven E Bosinger; Guido Silvestri; Françoise Barré-Sinoussi; Pierre Lebon; Olivier Schwartz; Michaela C Müller-Trutwin
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

3.  Epithelial adhesion molecules can inhibit HIV-1-specific CD8⁺ T-cell functions.

Authors:  Hendrik Streeck; Douglas S Kwon; Augustine Pyo; Michael Flanders; Mathieu F Chevalier; Kenneth Law; Boris Jülg; Kasper Trocha; Jonathan S Jolin; Melis N Anahtar; Jeff Lian; Ildiko Toth; Zabrina Brumme; J Judy Chang; Tyler Caron; Scott J Rodig; Danny A Milner; Alicja Piechoka-Trocha; Daniel E Kaufmann; Bruce D Walker; Marcus Altfeld
Journal:  Blood       Date:  2011-03-14       Impact factor: 22.113

4.  Persistent accumulation of gut macrophages with impaired phagocytic function correlates with SIV disease progression in macaques.

Authors:  Zachary D Swan; Anthea L Bouwer; Elizabeth R Wonderlich; Simon M Barratt-Boyes
Journal:  Eur J Immunol       Date:  2017-07-24       Impact factor: 5.532

5.  Comparison of simian immunodeficiency virus SIVagmVer replication and CD4+ T-cell dynamics in vervet and sabaeus African green monkeys.

Authors:  Simoy Goldstein; Charles R Brown; Ilnour Ourmanov; Ivona Pandrea; Alicia Buckler-White; Christopher Erb; Jayashree S Nandi; Gabriel J Foster; Patrick Autissier; Jörn E Schmitz; Vanessa M Hirsch
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

6.  Simian immunodeficiency virus SIVagm.sab infection of Caribbean African green monkeys: a new model for the study of SIV pathogenesis in natural hosts.

Authors:  Ivona Pandrea; Cristian Apetrei; Jason Dufour; Nora Dillon; Joseph Barbercheck; Michael Metzger; Béatrice Jacquelin; Rudolf Bohm; Preston A Marx; Françoise Barre-Sinoussi; Vanessa M Hirsch; Michaela C Müller-Trutwin; Andrew A Lackner; Ronald S Veazey
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

7.  Plasmacytoid dendritic cell dynamics and alpha interferon production during Simian immunodeficiency virus infection with a nonpathogenic outcome.

Authors:  Ousmane M Diop; Mickaël J-Y Ploquin; Lorenzo Mortara; Abdourahmane Faye; Béatrice Jacquelin; Désirée Kunkel; Pierre Lebon; Cécile Butor; Anne Hosmalin; Françoise Barré-Sinoussi; Michaela C Müller-Trutwin
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

8.  Primary simian immunodeficiency virus SIVmnd-2 infection in mandrills (Mandrillus sphinx).

Authors:  Richard Onanga; Sandrine Souquière; Maria Makuwa; Augustin Mouinga-Ondeme; François Simon; Cristian Apetrei; Pierre Roques
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

Review 9.  Into the wild: simian immunodeficiency virus (SIV) infection in natural hosts.

Authors:  Ivona Pandrea; Donald L Sodora; Guido Silvestri; Cristian Apetrei
Journal:  Trends Immunol       Date:  2008-09       Impact factor: 16.687

10.  Inhibition of adaptive immune responses leads to a fatal clinical outcome in SIV-infected pigtailed macaques but not vervet African green monkeys.

Authors:  Jörn E Schmitz; Roland C Zahn; Charles R Brown; Melisa D Rett; Ming Li; Haili Tang; Sarah Pryputniewicz; Russell A Byrum; Amitinder Kaur; David C Montefiori; Jonathan S Allan; Simoy Goldstein; Vanessa M Hirsch
Journal:  PLoS Pathog       Date:  2009-12-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.